COVID-19 Vaccines - Argentina

Argentina

Highlights

In Argentina, the revenue in the COVID-19 Vaccines market is projected to reach US$437.40m by 2024.
This indicates a promising growth potential for the country.
Looking ahead, the market is expected to exhibit an annual growth rate (CAGR 2024-2029) of -18.31%, leading to a market volume of US$159.10m by 2029.
It is worth noting that in a global perspective, United States is anticipated to generate the highest revenue of US$4.39bn in 2024.
Argentina is actively working on increasing the supply and distribution of COVID-19 vaccines to ensure widespread immunization across the country.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

Argentina, like many other countries, has been affected by the COVID-19 pandemic. The country has been actively working to secure vaccines for its population, and the COVID-19 Vaccines market in Argentina has been developing in response to these efforts.

Customer preferences: The Argentinian population has shown a strong interest in receiving the COVID-19 vaccine. In a recent survey, the majority of respondents expressed a willingness to be vaccinated. This is in line with global trends, as many countries are seeing high demand for COVID-19 vaccines.

Trends in the market: The COVID-19 Vaccines market in Argentina has seen a number of trends in recent months. One trend is the increasing availability of vaccines in the country. Argentina has secured agreements with several vaccine manufacturers, including Sinopharm and AstraZeneca, and has also participated in clinical trials for other vaccines.Another trend is the use of a vaccine passport system. The Argentinian government has implemented a system that allows individuals who have been vaccinated to access certain activities and services that are otherwise restricted. This has led to increased demand for vaccines among the population.

Local special circumstances: Argentina has faced a number of challenges in its efforts to secure vaccines for its population. The country has experienced economic difficulties in recent years, and this has made it more difficult to secure vaccine supplies. Additionally, the country has faced logistical challenges in distributing vaccines to its population, particularly in more remote areas.

Underlying macroeconomic factors: The COVID-19 Vaccines market in Argentina is influenced by a number of macroeconomic factors. One factor is the overall economic situation in the country. Argentina has experienced economic difficulties in recent years, and this has made it more difficult to secure vaccine supplies.Another factor is the political situation in the country. Argentina has experienced political instability in recent years, and this has led to uncertainty and instability in the healthcare sector. This has made it more difficult to implement effective vaccination programs and to secure vaccine supplies.Overall, the COVID-19 Vaccines market in Argentina is developing in response to the country's efforts to secure vaccines for its population. The increasing availability of vaccines, the use of a vaccine passport system, and the challenges faced by the country in securing vaccine supplies are all important factors shaping the market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.